BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1991836)

  • 1. Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block.
    Tay DL; Bhathal PS; Fox RM
    J Clin Invest; 1991 Feb; 87(2):519-27. PubMed ID: 1991836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.
    Mann GJ; Musgrove EA; Fox RM; Thelander L
    Cancer Res; 1988 Sep; 48(18):5151-6. PubMed ID: 3044582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivariate flow cytometric analysis of DNA content versus immunopositivity for ribonucleotide reductase M1 subunit in the cell cycle.
    Mangiarotti R; Bottone MG; Danova M; Pellicciari C
    Cytometry; 1998 Jun; 32(2):78-85. PubMed ID: 9627220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
    Sutherland RL; Hall RE; Taylor IW
    Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
    Kucera R; Brown CL; Paulus H
    J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 'non-proliferating' B16 melanoma cells using monoclonal antibody (AD203) against the M1 subunit of ribonucleotide reductase.
    Wong WS; Mann GJ; Tattersall MH
    Cell Tissue Kinet; 1988 Sep; 21(5):353-61. PubMed ID: 3073013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
    Bruno S; Giaretti W; Darzynkiewicz Z
    J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M; Monet JD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.
    Villman K; Ståhl E; Liljegren G; Tidefelt U; Karlsson MG
    Mod Pathol; 2002 May; 15(5):486-91. PubMed ID: 12011253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).
    El-Sherbiny YM; Cox MC; Ismail ZA; Shamsuddin AM; Vucenik I
    Anticancer Res; 2001; 21(4A):2393-403. PubMed ID: 11724298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome aberrations in normal human fibroblasts analyzed in G0/G1 and G2/M phases after exposure in G0 to radiation with different linear energy transfer (LET).
    Liu C; Kawata T; Furusawa Y; Zhou G; Inoue K; Fukada J; Kota R; George K; Cucinotta F; Okayasu R
    Mutat Res; 2013 Aug; 756(1-2):101-7. PubMed ID: 23688614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
    Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
    Ann N Y Acad Sci; 1993 Nov; 698():174-81. PubMed ID: 7904138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided S-phase fraction determination in DNA static cytometry in breast cancer. A preliminary methodologic study on cytologic material.
    Montironi R; Diamanti L; Santinelli A; Scarpelli M
    Anal Quant Cytol Histol; 1992 Oct; 14(5):379-85. PubMed ID: 1284372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
    Pellicciari C; Mangiarotti R; Bottone MG; Danova M; Wang E
    Cytometry; 1995 Dec; 21(4):329-37. PubMed ID: 8608730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors.
    Vartholomatos G; Alexiou GA; Stefanaki K; Lykoudis EG; Tseka G; Tzoufi M; Sfakianos G; Prodromou N
    Clin Neurol Neurosurg; 2015 Jun; 133():70-4. PubMed ID: 25867234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
    Doihara H; Takashima S; Saeki H; Takiyama W; Kurita A; Soga H; Tanada M; Yokoyama N; Moriwaki S
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2057-62. PubMed ID: 2145805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-related proteins: a flow cytofluorometric study in human tumors.
    Danova M; Riccardi A; Giordano M; Girino M; Mazzini G; Dezza L; Ascari E
    Biol Cell; 1988; 64(1):23-8. PubMed ID: 2906262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry of mitotic cells.
    Anderson HJ; de Jong G; Vincent I; Roberge M
    Exp Cell Res; 1998 Feb; 238(2):498-502. PubMed ID: 9473359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.